Literature DB >> 25017877

2nd European Conference on the Biology of Hydrogen Sulfide, Exeter, England 8th-11th September 2013.

Matt Whiteman1, Christopher Kevil2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25017877      PMCID： PMC4816209          DOI： 10.1016/j.niox.2014.07.001

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN： 1089-8603            Impact factor:   4.427


× No keyword cloud information.
  15 in total

1.  AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.

Authors:  Bartosz Szczesny; Katalin Módis; Kazunori Yanagi; Ciro Coletta; Sophie Le Trionnaire; Alexis Perry; Mark E Wood; Matthew Whiteman; Csaba Szabo
Journal:  Nitric Oxide       Date:  2014-04-19       Impact factor: 4.427

2.  Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer.

Authors:  Csaba Szabo; Ciro Coletta; Celia Chao; Katalin Módis; Bartosz Szczesny; Andreas Papapetropoulos; Mark R Hellmich
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-08       Impact factor: 11.205

Review 3.  Hydrogen sulfide and the liver.

Authors:  Sarathi Mani; Wei Cao; Lingyun Wu; Rui Wang
Journal:  Nitric Oxide       Date:  2014-02-26       Impact factor: 4.427

Review 4.  Hydrogen sulfide in plants: from dissipation of excess sulfur to signaling molecule.

Authors:  Alexander Calderwood; Stanislav Kopriva
Journal:  Nitric Oxide       Date:  2014-02-26       Impact factor: 4.427

5.  Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.

Authors:  Wagdi Elsheikh; Rory W Blackler; Kyle L Flannigan; John L Wallace
Journal:  Nitric Oxide       Date:  2014-04-18       Impact factor: 4.427

6.  SPRC protects hypoxia and re-oxygenation injury by improving rat cardiac contractile function and intracellular calcium handling.

Authors:  Yong-Hua Liang; Ya-Qi Shen; Wei Guo; Yi-Zhun Zhu
Journal:  Nitric Oxide       Date:  2014-06-02       Impact factor: 4.427

7.  Chemical characterization of the smallest S-nitrosothiol, HSNO; cellular cross-talk of H2S and S-nitrosothiols.

Authors:  Milos R Filipovic; Jan Lj Miljkovic; Thomas Nauser; Maksim Royzen; Katharina Klos; Tatyana Shubina; Willem H Koppenol; Stephen J Lippard; Ivana Ivanović-Burmazović
Journal:  J Am Chem Soc       Date:  2012-07-17       Impact factor: 15.419

8.  The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo.

Authors:  Zheng Wei Lee; Jianbiao Zhou; Chien-Shing Chen; Yujun Zhao; Choon-Hong Tan; Ling Li; Philip Keith Moore; Lih-Wen Deng
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

9.  Nitrosopersulfide (SSNO(-)) accounts for sustained NO bioactivity of S-nitrosothiols following reaction with sulfide.

Authors:  Miriam M Cortese-Krott; Bernadette O Fernandez; José L T Santos; Evanthia Mergia; Marian Grman; Péter Nagy; Malte Kelm; Anthony Butler; Martin Feelisch
Journal:  Redox Biol       Date:  2014-01-11       Impact factor: 11.799

10.  Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE).

Authors:  Antonia Asimakopoulou; Panagiotis Panopoulos; Christos T Chasapis; Ciro Coletta; Zongmin Zhou; Giuseppe Cirino; Athanassios Giannis; Csaba Szabo; Georgios A Spyroulias; Andreas Papapetropoulos
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.